Patents by Inventor Lauranell Burch

Lauranell Burch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYMORPHISM IN TRYPTOPHAN HYDROXYLASE-2 CONTROLS BRAIN SEROTONIN SYNTHESIS
    Publication number: 20100256116
    Abstract: A method of screening a subject for a serotonergic neurotransmission dysregulation disorder comprises detecting the presence or absence of an Tph2 mutation in the subject; and then determining that the subject is at increased risk of a serotonergic neurotransmission dysregulation disorder due to the presence or absence of the Tph2 mutation.
    Type: Application
    Filed: July 28, 2009
    Publication date: October 7, 2010
    Inventors: Marc G. Caron, Xiaodong Zhang, Martin Beaulieu, Raul R. Gainetdinov, Tatiana D. Sotnikova, Ranga R. Krishnan, David A. Schwartz, Redford B. Williams, Lauranell Burch
  • Polymorphism in tryptophan hydroxylase-2 controls brain serotonin synthesis
    Patent number: 7585627
    Abstract: A method of screening a subject for a serotonergic neurotransmission dysregulation disorder comprises detecting the presence or absence of an Tph2 mutation in the subject; and then determining that the subject is at increased risk of a serotonergic neurotransmission dysregulation disorder due to the presence or absence of the Tph2 mutation.
    Type: Grant
    Filed: May 20, 2005
    Date of Patent: September 8, 2009
    Assignee: Duke University
    Inventors: Marc G. Caron, Xiaodong Zhang, Martin Beaulieu, Raul R. Gainetdinov, Tatiana D. Sotnikova, Ranga R. Krishnan, David A. Schwartz, Lauranell Burch, Redford B. Williams
  • Polymorphism in tryptophan hydroxylase-2 controls brain serotonin synthesis
    Publication number: 20060029951
    Abstract: A method of screening a subject for a serotonergic neurotransmission dysregulation disorder comprises detecting the presence or absence of an Tph2 mutation in the subject; and then determining that the subject is at increased risk of a serotonergic neurotransmission dysregulation disorder due to the presence or absence of the Tph2 mutation.
    Type: Application
    Filed: May 20, 2005
    Publication date: February 9, 2006
    Inventors: Marc Caron, Xiaodong Zhang, Martin Beaulieu, Raul Gainetdinov, Tatiana Sotnikova, Ranga Krishnan, David Schwartz, Lauranell Burch, Redford Williams